Catalytic Enantioselective Synthesis of 4-Amino-1,2,3,4-tetrahydropyridine Derivatives from Intramolecular Nucleophilic Addition Reaction of Tertiary Enamides

Shuo Tong; Mei-Xiang Wang

doi:10.1055/s-0037-1610384

Synlett, Table of Contents

CC BY ND NC 4.0 · Synlett 2019; 30(04): 483-487
DOI: 10.1055/s-0037-1610384

letter

Copyright with the author

Catalytic Enantioselective Synthesis of 4-Amino-1,2,3,4-tetrahydropyridine Derivatives from Intramolecular Nucleophilic Addition Reaction of Tertiary Enamides

Shuo Tong*

,

Mei-Xiang Wang *

MOE Key Laboratory of Bioorganic Phosphorous Chemistry and Chemical Biology, Department of Chemistry, Tsinghua University, Beijing 100084, P. R. of China Email: tongshuo@mail.tsinghua.edu.cn Email: wangmx@mail.tsinghua.edu.cn

› Author Affiliations

Abstract

All articles of this category

Published as part of the 30 Years SYNLETT – Pearl Anniversary Issue

Abstract

A general and efficient method for the synthesis of highly enantiopure 4-amino-1,2,3,4-tetradydropyridine derivatives based on chiral phosphoric acid catalyzed intramolecular nucleophilic addition of tertiary enamides to imines has been developed. We have also demonstrated a substrate engineering strategy to significantly improve the enantioselectivity of asymmetric catalysis

Key words

tertiary enamides - 1,2,3,4-tetrahydropyridines - asymmetric catalysis - chiral phosphoric acid - substrate engineering

Full Text

References

References and Notes
1 Watson PS, Jiang B, Scott B. Org. Lett. 2000; 2: 3679

2a Ofner S, Hauser K, Schilling W, Vassout A, Veenstra SJ. Bioorg. Med. Chem. Lett. 1996; 6: 1623
2b Veenstra SJ, Hauser K, Schilling W, Betschart C, Ofner S. Bioorg. Med. Chem. Lett. 1996; 6: 3029

3 Patrizio M, Markus B, Patrick DG, Holger F, Michael H, Joerg H, Buelent K, Bernd K, Bernd ML, Alexander M, Robert N, Etienne R, Elena S, Urs S. Bio. Med. Chem. Lett. 2010; 20: 11009

4a Van Niel MB, Collins I, Beer MS, Broughton HB, Cheng SK. F, Goodacre SC, Heald A, Locker KL, MacLeod AM, Morrison D, Moyes CR, O’Connor D, Pike A, Rowley M, Russell MG. N, Sohal B, Stanton JA, Thomas S, Verrier H, Watt AP, Castro JL. J. Med. Chem. 1999; 42: 2087
4b Lübbers T, Böhringer M, Gobbi L, Hennig M, Hunziker D, Kuhn B, Löffler B, Mattei P, Narquizian R, Peters J.-U, Ruff Y, Wessel HP, Wyss P. Bioorg. Med. Chem. Lett. 2007; 17: 2966
4c Benmehdi H, Lamouri A, Serradji N, Pallois F, Heymans F. Eur. J. Org. Chem. 2008; 299
4d Barluenga J, Mateos C, Aznar F, Valdés C. Org. Lett. 2002; 4: 3667
4e Badorrey R, Portaña E, Díaz-de-Villegas MD, Gálvez JA. Org. Biomol. Chem. 2009; 7: 2912

5a Sun H, Scott DO. ACS Med. Chem. Lett. 2011; 2: 638 ; and references cited therein
5b Manetti D, Martini E, Ghelardini C, Dei S, Galeotti N, Guandalini L, Romanelli MN, Scapecchi S, Teodori E, Bartolini A, Gualtieri F. Bioorg. Med. Chem. Lett. 2003; 13: 2303

For reviews of enamide syntheses, see:

6a Dehli JR, Legros J, Bolm C. Chem. Commun. 2005; 973
6b Tracey MR, Hsung RP, Antoline J, Kurtz KC, Shen L, Slafer BW, Zhang Y. Category 3, Compounds with Four and Three Carbon Heteroatom Bonds . In Science of Synthesis . Vol. 21. Weinreb SM. Thieme; Stuttgart: 2005: 387

7 For an overview, see: Wang M.-X. Chem Commun. 2015; 51: 6039
8 Carbery DR. Org. Biomol. Chem. 2008; 6: 3455
9 Gopalaiah K, Kagan HB. Chem. Rev. 2011; 111: 4599

Secondary enamides are active aza-ene components to undergo aza-ene addition reactions with highly electron-deficient unsaturated compounds. For reviews, see:

10a Matsubara R, Kobayashi S. Acc. Chem. Res. 2008; 41: 292
10b Bernadat G, Masson G. Synlett 2014; 25: 2842

11a Yang L, Deng G, Wang D.-X, Huang Z.-T, Zhu J, Wang M.-X. Org. Lett. 2007; 9: 1387
11b Yang L, Zheng Q.-Y, Wang D.-X, Huang Z.-T, Wang M.-X. Org. Lett. 2008; 10: 2461
11c Yang L, Lei C.-H, Wang D.-X, Huang Z.-T, Wang M.-X. Org. Lett. 2010; 12: 3918

12a Yang L, Wang D.-X, Huang Z.-T, Wang M.-X. J. Am. Chem. Soc. 2009; 131: 10390
12b Tong S, Wang D.-X, Zhao L, Zhu J, Wang M.-X. Angew. Chem. Int. Ed. 2012; 51: 4417
12c He L, Zhao L, Wang D.-X, Wang M.-X. Org. Lett. 2014; 16: 5972
12d Zhu W, Zhao L, Wang M-X. J. Org. Chem. 2015; 80: 12047
12e Xu X.-M, Zhao L, Zhu J, Wang M.-X. Angew. Chem. Int. Ed. 2016; 55: 3799
12f Xu X.-M, Lei C.-H, Tong S, Zhu J, Wang M.-X. Org. Chem. Front. 2018; 5: 3138

13a Shono T, Matsumura Y, Tsubata K, Sugihara Y, Yamane S, Kanazawa T, Aoki T. J. Am. Chem. Soc. 1982; 104: 6697
13b Andan L, Miesch L. Org. Lett. 2018; 20: 3430

14a Lei C.-H, Wang D.-X, Zhao L, Zhu J, Wang M.-X. J. Am. Chem. Soc. 2013; 135: 4708
14b Lei C.-H, Wang D.-X, Zhao L, Zhu J, Wang M.-X. Chem. Eur. J. 2013; 19: 16981

15 Zhang X.-Y, Xu X.-M, Zhao L, You J, Zhu J, Wang M.-X. Tetrahedron Lett. 2015; 56: 3898
16 Tong S, Yang X, Wang D.-X, Zhao L, Zhu J, Wang M.-X. Tetrahedron 2012; 68: 6492
17 Zhou Q.-L. Privileged Chiral Ligands and Catalysts . Wiley-VCH; Weinheim: 2011

18a Akiyama T, Itoh J, Fuchibe K. Angew. Chem. Int. Ed. 2004; 43: 1566
18b Yamanaka M, Itoch J, Fuchibe K, Akiyama T. J. Am. Chem. Soc. 2007; 129: 6756

19 Uraguchi D, Terada M. J. Am. Chem. Soc. 2004; 126: 5356

For recent reviews on chiral phosphoric acids, see:

20a Parmar D, Sugiono E, Raja S, Rueping M. Chem. Rev. 2014; 114: 9047
20b Lv J, Luo S. Chem. Commun. 2013; 49: 847
20c Li P, Yamamoto H. Top. Curr. Chem. 2011; 37: 161
20d Yu J, Shi F, Gong LZ. Acc. Chem. Res. 2011; 44: 1156
20e Kampen D, Reisinger CM, List B. Top. Curr. Chem. 2010; 291: 395
20f Mahlan M, List B. Angew. Chem. Int. Ed. 2013; 52: 518
20g Terada M. Synthesis 2010; 1929
20h Hatano M, Ishihara K. Synthesis 2010; 3785
20i Zamfir A, Schenker S, Freund M, Tsogoeva SB. Org. Biomol. Chem. 2010; 8: 5262
20j Yu X, Wang W. Chem. Asian J. 2008; 3: 516
20k Akiyama T. Chem. Rev. 2007; 107: 5744

21a Nelson DL, Cox MM. Lehninger Principles of Biochemistry . W. H. Freeman and Company; New York: 2005. 4th ed., Chap. 6
21b Faber K. Biotransformations in Organic Chemistry . Springer; Berlin: 1997. 3rd ed. Chap. 1

For select examples about substrate engineering in biocatalytic transformations, see:

22a Braunegg G, De Raadt A, Feichtenhofer S, Griengl H, Kopper I, Lehmann A, Weber H.-J. Angew. Chem. Int. Ed. 1999; 38: 2763
22b De Raadt A, Griengl H, Weber H. Chem. Eur. J. 2001; 7: 27
22c Ma D.-Y, Zheng Q.-Y, Wang D.-X, Wang M.-X. Org. Lett. 2006; 8: 3231
22d Ma D.-Y, Wang D.-X, Pan J, Huang Z.-T, Wang M.-X. J. Org. Chem. 2008; 73: 4087

23 General Reaction Procedure A mixture of enamides 1a (0.5 mmol) and amines 2b (0.5 mmol) in dry CCl₄ (25 mL) was stirred at ambient temperature for 5 min. Chiral phosphoric acid catalyst CC8 (75 mg, 0.1 mmol, 0.2 equiv) was added to the reaction system. Upon completion of the reaction, which was monitored by TLC, the reaction mixture was quenched with 10 mL sat. NaHCO₃ solution, then extracted with 3 × 10 mL CH₂Cl₂. The combined organic layers were washed with brine and dried over anhydrous sodium sulfate. After removal of the solvent, the residue was purified by column chromatography on silica gel to yield pure product 4ab. Oil (98% yield); ee 88.8% (chiral HPLC analysis). IR (KBr): 3422, 1723, 1656, 1601 cm^–1. ¹H NMR (400 MHz, CDCl₃): δ = 7.21–7.44 (m, 17 H), 6.99 (br s, 2 H), 5.50 (br s, 1 H), 5.08 (s, 1 H), 4.05 (br s, 1 H), 3.74 (br s, 1 H), 3.41 (br s, 1 H), 2.00 (br s, 2 H), 1.62 (br s, 1 H). ¹³C NMR (100 MHz, CDCl₃): δ = 170.9, 144.0, 143.8, 140.6, 137.8, 136.2, 131.2, 130.7, 128.7, 128.6, 128.3, 128.1, 127.5, 127.34, 127.27, 127.2, 121.3, 118.6, 64.4, 48.8, 44.1, 31.2. HRMS (ESI): m/z calcd for C₃₁H₂₇BrN₂O [M + Na]⁺, [M + 2 + Na]⁺: 521.1229, 523.1213; found: 521.1226, 523.1216.

Supplementary Material

Supporting Information